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Many terminal human diseases are caused by mutations affecting mitochondrial functioning.  
Mitochondria are essential organelles responsible for producing cellular energy, adenosine 
triphosphate (ATP) via oxidative phosphorylation (OXPHOS) at mitochondrial electron 
transport chains (ETC). Proper ETC functioning relies on maintenance of the electrochemical 
gradient essential for energy production, known as mitochondrial membrane potential (∆ψM). 
The inner mitochondrial membrane is the site of the ETC and is most closely in contact with the 
enzymatic processes occurring within the mitochondrial matrix. Mutations affecting protein 
components of the ETC are especially troublesome for organelle health. ETC mutants commonly 
express altered ∆ψM, as well as increased production of damaging reactive oxygen species 
(ROS), which are hypothesized to cause genomic damage and lasting mutation. The nematode C. 
elegans is a practical model organism for investigating the phenotypic and genomic consequences 
of ETC mutations. Despite expressing higher levels of damaging ROS, the ETC protein complex 1 
mutant, gas-1, expresses heritable mtDNA and nDNA mutation rates identical to those of wild type 
animals. I am using a mitochondria-targeted dye and fluorescence microscopy to quantify and 
compare ∆ψM levels of the gas-1 mutant and wild type animals. This work will provide a novel 
phenotypic characterization of this mutant and indicate whether decreased metabolic activity (e.g., 
reduced reliance on OXPHOS) is occurring in gas-1, and perhaps conferring protection from 
genomic degradation. Based on gas-1’s characteristically low ATP production and high ROS 



































Mitochondria are arguably the most important organelle to cellular health and performance because 
they are the site of bioenergy metabolism for the entire cell. Glucose is digested and sent to the 
Citric Acid Cycle (TCA) located in the mitochondrial cytoplasm in the form of pyruvate, which is 
then metabolized to provide electrons in the form of NADH and FADH2 for use in oxidative 
phosphorylation (OXPHOS) occurring at the mitochondrial electron transport chain (ETC). The ETC 
is comprised of a series of proteins, organized into supercomplexes, located along the inner 
mitochondrial membrane. The movement of electrons through the complexes of the ETC produces 
more cellular energy in the form of ATP than glycolysis and the tricarboxylic acid cycle (TCA) cycle 
combined, and is powered by the constant movement of ions across the inner membrane, known 
as an electrochemical gradient, or the inner mitochondrial membrane potential (∆ψM).   
  
Mutations in both nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) can be responsible for 
coded dysfunction in a mitochondrion. Mutations affecting the ETC will consequently inhibit the 
production of ATP via OXPHOS and possibly other important regulatory functions of mitochondria. 
In addition to its central role in ETC and cellular function, maintenance of ∆ψM is crucial for the 
process of mitochondrial fusion, and excessive fragmentation (fission) of mitochondria results when 
∆ψM is disrupted due to overwhelming proton translocator activity (Legros, 2002). Cycles of 
mitochondrial fission and fusion are crucial to overall cell health; however, only mitochondrial 
fusion is dependent upon ∆ψM (Legros, 2002). Because mitochondrial function is crucial for energy 
metabolism, dysfunctions within these organelles can lead to a broad range of diseases in animals, 
including Parkinson’s disease in humans (Celardo, Martins, and Gandhi, 2014).  
 
Complex 1 of the ETC is specifically responsible for the oxidation of NADH to lone electrons and 
protons and creating the initial proton gradient along the inner mitochondrial membrane, which 
initiates energy production through OXPHOS. This movement of ions is the main source of reactive 
oxygen species (ROS) due to electron leakage onto molecular oxygen, which is ever present due to 
the nature of this process (Hicks, Denver, and Estes, 2013). Although some ROS are critically 
important for molecular signaling, at high levels they are damaging to proteins, can cause 
morphological changes in mitochondria, disrupt ∆ψM, delay organismal development, and cause 
oxidative damage to DNA and lasting mutation (Shibuya and Tsujimoto, 2012).  The idea that ROS-
induced oxidative damage is an important source of somatic (non-gamete) or heritable (germline) 
mutation in nDNA or mtDNA genomes is controversial (Griffiths et al., 2000).  
 
Altered metabolic processes were first observed in colorectal cancer cells (Warburg et al., 1956). 
The Warburg Effect is a phenomenon characterized by a shift in metabolism from primary use of 
OXPHOS to a less oxidatively stressful (i.e., lower ROS producing) but much less energetically 
efficient mixture of aerobic glycolysis and OXPHOS, which benefits rapidly proliferating cells (1956; 
Lunt and VanderHeiden, 2011). Ericson et al. (2012) measured the frequency of random de novo 
single base substitutions in the mtDNA of human colorectal cancer cells and discovered that tumor 
tissue had fewer C:G to T:A transition mutations (known to be associated with oxidative damage) 
compared to healthy colorectal tissue cells. Ericson et al. (2012) also showed that this decrease in 
mutation frequency was coupled with a metabolic shift from OXPHOS to anaerobic glycolysis, which 
was not witnessed in healthy colorectal cells. These findings suggest that the stability of the 
mitochondrial genome is increased in cancer compared to healthy cells, as a result of a decrease in 
ROS related mtDNA damage. Inhibited or suppressed energy production has also been observed in 
a wide variety of other diseases, including diabetes and neurodegenerative disorders (DeBerardinis, 
2012).  However, whether and to what extent altered or depressed metabolism can protect 
organisms from heritable (germline) mutations has not been studied. 
 
C. elegans nematodes are becoming an increasingly important model system for studying 
mitochondrial dysfunction and its relationship with energy metabolism and mutation.  These 
 microscopic animals are easy to maintain, transparent, non-parasitic, and can be used for studying 
the effects of mutation on individuals and populations with relative ease. Among several ETC 
mutant alleles available for C. elegans, gas-1 (fc21) is particularly well-studied. gas-1 is a nuclear 
gene and gas-1 (fc21) is a single base pair substitution that creates a hypomorphic allele in a 
protein component of ETC complex 1 
(http://www.wormbase.org/species/c_elegans/gene/WBGene00001520?query=gas-1#0-9e-3). 
gas-1 expresses many altered physiological phenotypes such as increased dependence on ETC 
complex II to maintain metabolic homeostasis, decreased growth rate, decreased fecundity, a 
characteristic hypersensitivity to volatile anesthetics, increased levels of ROS, and decreased 
OXPHOS abilities as compared to that of wild type (Kayser et at., 2001). Despite the fact that gas-
1 mutants exhibit elevated levels of damaging ROS, previous studies performed by the D. R. 
Denver lab (Oregon State Univ.) have concluded that both mtDNA and nDNA mutation rates in gas-
1 are identical to those expressed by wild type animals (Estes pers. comm.). This result may 
indicate that ROS do not affect heritable mutation rates as previously thought. Based on these and 
previous findings, we believe that gas-1 is experiencing a shift in metabolism synonymous with the 
Warburg Effect, and as a result, is gaining genomic protection from the mutagenic effects of high 
levels of ROS by reducing its dependence on energy production via the OXPHOS pathway (c.f., 
Ericson et al., 2012).  
 
Previous phenotyping of gas-1 has included various life-history and physiological traits (Kayser et 
al., 2001; Cairo et al., 1992; Estes et al., unpubl.), and studies of gene expression (Falk et al. 
2008); however, ∆ψM has not yet been characterized. Further investigation of gas-1 is necessary 
to understand the effects of mutation on the ETC metabolic process, as well as the possibility of 
genomic preservation by means of altered metabolic pathways. By quantifying and comparing inner 
∆ψM of the mutant gas-1 to that of wild type animals, it will be possible to gain an understanding 
of the effects of the gas-1 mutation on energy production in C. elegans. Because ∆ψM drives 
production of ATP via OXPHOS, these data allow us to detect any change in reliance of gas-1 on 
this pathway and whether a shift in metabolism may be providing genomic protection for the gas-1 
mutant.  
 
Materials & Methods 
 
Nematode culture conditions.  
 
The C. elegans N2 strain and the nuclear mutant, gas-1(fc21), were obtained from the 
Caenorhabditis Genetics Center (University of Minnesota). Prior to experimentation, the D. R. 
Denver lab (Oregon State University) generated a completely isogenic gas-1 mutant strain via 10 
generations of backcrossing to the N2 strain during which the gas-1(fc21) allele was tracked by 
PCR and Sanger DNA sequencing. Nematodes were thawed from a -80°C±2°C freeze and then kept 
on 60mm Petri plates containing 15mL of NGM-Lite agar that had been treated with 20 µg/mL 
streptomycin and seeded with OP50-1 Escherichia coli as a food source. Worms were regularly 
transferred to new plates with the use of a sterilized platinum scalpel to maintain small population 
sizes, avoid starvation, and decrease risk of bacterial contamination. Strains were stored in a dark, 
20°C incubator. Populations no older than 30 days were used in data collection. 
 
Fluorescence microscopy.  
 
All methods were adapted from Hicks et al. (2012). When a sufficient number of worms from both 
strains had reached adulthood, their eggs were harvested to ensure age-synchronicity during 
future data collection. Age-synchronization was achieved by repeatedly rinsing samples with M9 
buffer solution, dissolving adult worms with a 2:1 NaOH:bleach solution, and frequent 
centrifugation to promote sedimentation of egg pellets (Hicks et al., 2012).  
 
 After the harvested eggs had matured on fresh plates for 24-58 hours, they were allowed to feed 
on fluorescently dyed E. coli for 24 hours (Hicks et al., 2012). A solution of 5µL of Chloromethyl-X-
Rosamine (CMXROS) diluted with 495µL of M9 buffer solution was used per plate. CMXROS is a 
lipophillic, cationic, fluorescent dye that selectively binds to negatively charged components within 
the inner mitochondrial membranes of the worms (Pendergrass, Wolf, and Poot, 2004). The worms 
were then rinsed in M9 buffer solution and allowed to feed on un-dyed E. coli for 1 hour to pass 
any residual dyed E. coli from their intestinal tracts. Immediately prior to imaging, all worms were 
treated with a 20 mM solution of paralytic levamisole. The pharyngeal bulb of each worm was 
imaged at a total magnification of 25X, with the use of a fluorescence stereoscopic dissecting 
microscope (Leica MSV269). This neuromuscular organ was chosen to quantify ∆ψM because of the 
large amount of localized mitochondria typically found within the boundaries of the bulb (Hicks, et 
al. 2012). It is also a site that contains minimal amounts of auto-fluorescent fat deposits, which 
decreases the likelihood of fluorescent interference during imaging.  
 
Image processing and data analysis.  
 
After images were collected, each bulb was manually encapsulated using ImageJ software (NIH). 
They were then analyzed by measuring mean and maximum fluorescence values and total area of 
each bulb in ImageJ. Statistical comparison of the two strains was achieved using a non-parametric 
Wilcoxon chi-square approximation (first data set) or a Student’s t-test (second data set) 
performed in JMP 9.0 (SAS). During image analysis, it became apparent that half of the nematodes 
comprising the first data set had not matured to the young adult stage prior to imaging. Because of 
this, a second set of data was collected and analyzed after the new sample had been verified to be 




Two sets of data from a total of three imaging sessions that took place in July and August were 
analyzed separately. Data were grouped in this fashion due to among-assay differences in 
nematode developmental stage (above). The first set of data (Figure 1) indicated that gas-1 
exhibited significantly lower levels of ∆ψM than the wildtype N2 strain (Wilcoxon χ²= 14.3, df = 1, 
N = 133, p = 0.0002). Analysis of mean pixel intensity showed an identical pattern (data not 
shown). The second set of data (Figure 2.1) showed that gas-1 trended toward higher ∆ψM levels 
than the wildtype N2 strain (t = -1.44, df = 1, N = 77, p = 0.1547), although the difference was 
not statistically significant. It was also observed that the wildtype strain had significantly larger 




Figure 1: gas-1 strain exhibits lower 
levels of average maximum fluorescence 
within pharyngeal bulbs stained with 
MitoTracker CMXROS. Maximum 
fluorescence is measured in pixel intensity, Y-




The first set of data (N =133) indicated that 
gas-1 exhibited lower ∆ψM than that of 
wildtype N2 (Figure 1), although upon closer 
inspection it was determined that the animals 
were not imaged at the appropriate young 
adult stage necessary for accurate data 
collection. As C. elegans reaches maturity, it 
experiences a marked increase in the 
numbers of mitochondria accompanied by a 
shift in primary metabolic reliance from the 
TCA cycle/glyoxylate cycle to OXPHOS 
(Intermediary metabolism: Metabolic patterns 
during development and aging: 7-9, 
Wormbook, 2009); therefore, a lack of 
metabolic maturity could underlie the lower 
∆ψM of gas-1 compared to the wildtype N2 
strain. Results from the second set of data (N 
= 77), which used a verified young adult 
population, suggested that the gas-1 
population expressed higher levels of ∆ψM 
than that of the wildtype population (Figure 
2.1), although the difference was not 
statistically significant. This observation could 
indicate that the gas-1 mutation affecting ETC 
Complex 1 prohibits dissipation of ∆ψM down 
the ETC, resulting in a highly polarized 
electrochemical gradient, which could also be 
contributing to gas-1’s characteristically high 
ROS levels and abnormally low level of ATP 
production (Brand, 2000). The second set of 
data also revealed that gas-1 had significantly 
smaller mean pharyngeal bulb areas than 
those of N2 (Figure 2.2). This large difference 
in bulb size between strains could be 
explained by the less efficient and less 
healthy metabolism of gas-1. Similarly, it is 
well-understood that the movement of the 
pharynx, or pharyngeal pumping, is 
recognized as a proxy for metabolic rate in C. 
elegans (Collins, 2008).  
 
Future work will conduct additional trials 
using a larger sample size will be used during 
data collection, and use confocal fluorescence 
microscopy, which will allow imaging of 
separate focal planes at higher magnification 
and increased resolution. This experiment will 
also be repeated using ten mutation-
accumulation (MA) lines generated from 
either gas-1 or N2 (in addition to the gas-1 
and N2 progenitor strains) to further explore 
the possibility of a shift in metabolism from 
OXPHOS to glycolysis among lines that have 
accumulate mutations under genetic drift 
against either the gas-1 mutant or wildtype 
genetic background.  Based on my 
preliminary findings, I would expect that gas-
1 MA lines would show further increased ∆ψM  
 
 levels and would show greater variability in 
∆ψM levels from gas-1 progenitor than N2 MA 
lines would show compared to N2 progenitor. 
In contrast, I would expect N2 MA lines to 
have similar or lower levels of ∆ψM compared 
to N2 progenitor.  
 
Figure 2.1: gas-1 strain exhibits higher average 
maximum fluorescence within pharyngeal bulbs 
stained with MitoTracker CMXROS than that of  
wildtype. Maximum fluorescence is measured in  




Figure 2.2: gas-1 strain exhibits smaller  
pharyngeal bulb area than that of wildtype N2  
when CMXROS stained organs are manually  
encapsulated and measured with ImageJ data 
analysis software. Pharynx area is measured in  
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